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Abstract
Nocardia cyriacigeorgica (N. cyriacigeorgica) is most frequently associated with human infections, including chronic
bronchitis, pulmonary disease and brain abscesses. In general, N. cyriacigeorgica causes infections in immunocompromised
individuals and has been reported in clinical samples worldwide. However, the isolation and speciation of N. cyriacigeorgica
in the routine diagnostic microbiology laboratory are complicated and time consuming. Recent mass spectrometry
techniques such as matrix-assisted laser desorption/ionization time-of-flight-mass spectrometry (MALDI-TOF-MS) have
been successfully integrated into many routine diagnostic microbiology laboratories, allowing for the rapid, accurate and
simple identification and speciation of many different microorganisms, including difficult-to-identify bacterial species.
Here, we present a case report of a 65-year-old female patient from the neurology ward of Prince Sultan Military Medical
City in Riyadh, Saudi Arabia, who was infected with N. cyriacigeorgica. The bacterium was successfully identified by
MALDI-TOF-MS, with species identification subsequently confirmed by sequence analysis of the 16S ribosomal RNA.
INTRODUCTION
In humans, Nocardia spp. predominantly causes pulmonary
nocardiosis [1]. However, Nocardia species are also capable of dis-
seminating from the primary site of infection, such as the lungs,
to other organs, including the central nervous system. As such,
Nocardia are capable of generating disease at different body sites,
including abscesses in the brain [2]. Although Nocardia infections
are primarily seen in patients with immunodeficiency, AIDS,
cancer and diabetes [3], cases have been reported in individuals
with fully functioning immune systems [4].
Among the Nocardia species, Nocardia cyriacigeorgica (N.
cyriacigeorgica) is an emerging pathogen that appears to be
adapting from environmental to human host [5]. The bacterium
is primarily found in soil, but can also live in stagnant water
and enter the human body through dust respiration and trau-
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isolation and identification of Nocardia species from clinical
samples within typical hospital laboratories is difficult and time
consuming when using conventional diagnostic methods [6].
One potential candidate method that allows for rapid and accu-
rate
identification of bacterial species is matrix-assisted laser
desorption/ionization time-of-flight (MALDI-TOF). In this case
report, we describe the use of MALDI-TOF for identifying
the bacterial species N. cyriacigeorgica, isolated from a brain
abscess. Species confirmation was obtained via subsequent 16S
ribosomal RNA (16S rRNA) gene sequencing.
CASE REPORT
A 65-year-old female was admitted to the emergency depart-
ment of Prince Sultan Military Medical City in Riyadh, Saudi
Arabia, complaining of headache, vomiting, dysarthria and
right-sided weakness. She had end-stage renal disease, relied
on hemodialysis, and suffered from ischemic heart disease,
idiopathic thrombocytopenia and hypothyroidism. The patient
subsequently underwent a magnetic resonance imaging (MRI)
scan, which showed a left-sided parietal lesion measuring
5 cm × 4.5 cm × 5 cm, with a midline shift (Fig. 1). The patient
was immediately admitted to the hospital, and surgery was
performed to aspirate material from the brain abscess. Gram
staining and acid fast staining of the brain abscess aspirate
did not show any bacteria, however, several white blood
cells were observed. The aspirate was grown on enrichment
medium (RCM) and also on solid media (nutrient agar) and
after 72 hours, bacterial growth was found on both media.
Conventional methods using biochemical testing and Gram-
staining failed to identify the bacterium present within the
bacterial colonies, therefore samples were prepared for MALDI-
TOF (Bruker MALDI Biotyper System) analysis. MALDI-TOF
identified the abscess bacterium as N. cyriacigeorgica, with a score
value of 2.11, indicating a ‘High Confidence Identification’ of the
bacterial species [7]. Species identification was subsequently
confirmed by sequencing of the 16S rRNA gene of the bacterial
isolate by an external reference laboratory (Mayo Clinic, AZ,
USA). Antibiotic susceptibility testing—using disc diffusion
and E-testing according to CLSI guidelines—showed that the
isolated N. cyriacigeorgica species was resistant to penicillin,
teicoplanin and vancomycin (intermediate), but susceptible
to cotrimoxazole, imipenem, fucidin and ceftriaxone [8]. The
patient received empirical antibiotic treatment with vancomycin
and ceftriaxone for 3 weeks. After 3 weeks, a follow-up MRI
showed the remaining presence of the lesion, which was excised
by craniotomy. An MRI taken following surgery showed no
abscess. Postoperatively the patient was found to be well and
discharged.
DISCUSSION
Nocardia species are Gram-positive, aerobic, branching and
filamentous bacteria belonging to the actinomycetes group
of bacteria, which are ubiquitously found in soil and water.
However, infections due to Nocardia are difficult and cum-
bersome to diagnose because they lack specific clinical signs
and do not exhibit pathognomonic features [3]. In addition,
the bacteria do not grow efficiently in culture media, leading
to slow or sometimes no growth, which may specifically be
because of the presence of other commensals. Because of these
issues, the identification of Nocardia at the species level in the
Figure 1: MRI showing a left parietal lesion measuring 5 cm × 4.5 cm × 5 cm, with
a midline shift.
routine diagnostic microbiology laboratory is very time consum-
ing, and accurate species identification is often not possible
using conventional techniques. Currently, the species identi-
fication of Nocardia is based on gene sequencing, specifically
sequencing of the 16S rRNA gene, which has become the ‘gold
standard’ [9]. The use of genetic-based species identification
methods such as 16S rRNA gene sequencing plays a vital role in
Nocardia species determination. Accordingly, these techniques
aid epidemiological investigations and provide a better under-
standing of the management and treatment of nocardiosis
infections because different Nocardia species may exhibit
different antimicrobial susceptibility patterns [8]. However,
genetic-based methods of identification are time consuming
and not always available in smaller diagnostic microbiology
laboratories; thus, accurate and rapid identification techniques
such as MALDI-TOF are showing their value in the current
diagnostic clinical microbiology laboratory. For example, in this
case report, initial pathogen identification was achieved using
MALDI-TOF, which has the potential to rapidly and accurately
identify Nocardia species in clinical samples [7]. However, given
the rarity of nocardial brain abscesses, the confirmation of the
genus/species identification using methods such as 16S rRNA
gene sequencing is still recommended.
The prolonged use of corticosteroids, organ transplantation,
the presence of cancer and human immunodeficiency virus
infection are considered to be the most common predisposing
factors for nocardial infections (nocardiosis) [2]. When nocardial
infection occurs, species such as N. farcinica, N. paucivorans,
N. asteroids, N. arthritidis and N. cerradoensis have been reported.
Among the Nocardia group, N. cyriacigeorgica is one of the
most often implicated species in human nocardiosis, including
septicemia, endophthalmitis, after liver transplantation, as sec-
ondary infections in patients with cancer, in pulmonary infec-
tions, cellulitis, spinal abscess, empyema and brain abscess [10].
In conclusion, brain abscesses associated with Nocardia
species are rare and this is the first case report of the
identification of N. cyriacigeorgica isolated from a cerebral abscess
in Saudi Arabia. The success of MALDI-TOF in the identification








aa088/5936349 by guest on 14 January 2021
Identification of Nocardia cyriacigeorgica 361
as N. cyriacigeorgica will help clinicians make effective clinical
decisions, particularly in the treatment of life-threatening
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